41962:SERUM INTEGRATED SCREEN, 2ND TRIMESTER
Author PeaceHealth Laboratories
 Print View Attached Docs: |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELISA) / Chemiluminescent Immunoassay (CLIA) |
| Edit Date: |
4/6/2009 |
| Components: |
Calculation of AFP MoM, hCG MoM, uE3 MoM, Inhibin-A MoM, PAPP-A MoM, risk for Down syndrome and Neural Tube Defect and Trisomy 18 Interpretations |
| Performed: |
Monday-Friday |
| Released: |
Within 48-72 hours of receipt. |
| CPT Code: |
82105 / 82677 / 84702 / 86336 |
| Specimen Collection Details |
| Collection: |
These requirements are for the second trimester draw for the Serum Integrated Screen, 2nd Trimester which can be performed only on individuals between 15 weeks, 0 days and 21 weeks, 6 days gestation, and who have had the Serum Integrated Screen, 1st Trimester (41989). Order on a PeaceHealth Laboratories Obstetrics requisition or electronically, and include any change from 1st trimester test in patient weight, due date, dating method (US, LMP), or number of fetuses. Collect one 7.5 mL serum separator tube (SST). Also acceptable: One 5 mL red top tube |
| Handling: |
Allow to clot, centrifuge, and separate serum from cells immediately. Refrigerate. |
| Stability: |
7 days refrigerated at 2-8° C, or 30 days frozen at -20° C. Allow no more than one freeze cycle. |
| Standard Volume: |
3 mL serum |
| Minimum Volume: |
1.5 mL serum |
| Transport: |
Refrigerated, or frozen on dry ice. |
| Rejection Criteria: |
Gross hemolysis or gross lipemia. |